warfarin and Bronchiectasis

warfarin has been researched along with Bronchiectasis* in 1 studies

Other Studies

1 other study(ies) available for warfarin and Bronchiectasis

ArticleYear
Antiplatelet or anticoagulant therapy might not increase the risk of haemoptysis in patients with bronchiectasis.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2013, Volume: 17, Issue:7

    The aim of this study was to assess whether the use of antiplatelets and anticoagulants increased haemoptysis in patients with bronchiectasis. Cases (n = 242) with a history of haemoptysis were compared with controls (n = 242) without a history of haemoptysis. Of the 242 case patients, 16.5% took antiplatelets compared with 19.8% of controls (P = 0.346). The proportion of warfarin users did not differ between cases and controls (3.3% vs. 2.5%, P = 0.588). The use of these agents might not be associated with increased risk of haemoptysis in patients with bronchiectasis.

    Topics: Aged; Anticoagulants; Bronchiectasis; Case-Control Studies; Female; Hemoptysis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Warfarin

2013